|
|
|
Insider
Information: |
Alton Gregg H |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
61,846 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,731,983 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
61,846 |
|
|
Total
Value |
$3,731,983 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-05-01 |
4 |
AS |
$68.31 |
$341,529 |
D/D |
(5,000) |
112,988 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-06-01 |
4 |
AS |
$65.02 |
$325,114 |
D/D |
(5,000) |
107,988 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-07-03 |
4 |
AS |
$71.06 |
$355,295 |
D/D |
(5,000) |
102,988 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-07-21 |
4 |
AS |
$74.00 |
$2,960,000 |
D/D |
(40,000) |
97,488 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-08-01 |
4 |
AS |
$75.88 |
$1,138,190 |
D/D |
(15,000) |
91,113 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-08-30 |
4 |
AS |
$79.00 |
$3,950,000 |
D/D |
(50,000) |
84,238 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-09-01 |
4 |
AS |
$82.96 |
$2,076,188 |
D/D |
(25,000) |
76,488 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-10-02 |
4 |
AS |
$81.84 |
$2,066,307 |
D/D |
(25,000) |
68,738 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-11-01 |
4 |
AS |
$74.74 |
$1,122,285 |
D/D |
(15,000) |
62,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-12-01 |
4 |
AS |
$74.46 |
$1,119,552 |
D/D |
(15,000) |
55,988 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2018-01-02 |
4 |
AS |
$72.34 |
$1,108,019 |
D/D |
(15,000) |
49,613 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2018-01-11 |
4 |
AS |
$79.00 |
$2,370,000 |
D/D |
(30,000) |
45,488 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-02-01 |
4 |
AS |
$83.29 |
$2,087,860 |
D/D |
(25,000) |
37,738 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-03-01 |
4 |
AS |
$77.64 |
$1,967,315 |
D/D |
(25,000) |
44,426 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
SVP, General Counsel |
|
2008-03-17 |
4 |
D |
$47.55 |
$124,153 |
D/D |
(2,611) |
54,716 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
SVP, General Counsel |
|
2009-03-02 |
4 |
D |
$44.13 |
$132,392 |
D/D |
(3,000) |
54,696 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
SVP, General Counsel |
|
2009-03-12 |
4 |
D |
$44.04 |
$106,269 |
D/D |
(2,413) |
52,993 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2010-03-08 |
4 |
D |
$47.01 |
$250,657 |
D/D |
(5,332) |
24,148 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2011-03-15 |
4/A |
D |
$39.79 |
$186,058 |
D/D |
(4,676) |
35,481 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2011-03-15 |
4 |
D |
$39.79 |
$155,062 |
D/D |
(3,897) |
34,590 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2012-03-12 |
4 |
D |
$46.16 |
$310,795 |
D/D |
(6,733) |
43,057 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2013-03-06 |
4 |
D |
$45.40 |
$663,294 |
D/D |
(14,610) |
71,938 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2014-03-06 |
4 |
D |
$79.92 |
$4,378,817 |
D/D |
(54,790) |
134,694 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2015-02-17 |
4 |
D |
$103.84 |
$6,935,889 |
D/D |
(66,794) |
149,422 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
|
2016-02-16 |
4 |
D |
$91.15 |
$2,988,444 |
D/D |
(32,786) |
152,090 |
0 |
- |
|
360 Records found
|
|
Page 5 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|